首页> 外文期刊>Experimental and clinical transplantation >Changes in Pulmonary Artery Pressure Affect Survival Differently in Lung Transplant Recipients Who Have Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease
【24h】

Changes in Pulmonary Artery Pressure Affect Survival Differently in Lung Transplant Recipients Who Have Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease

机译:肺动脉高压或慢性阻​​塞性肺疾病的肺移植受者肺动脉压的变化对生存的影响不同

获取原文
       

摘要

Objectives: Pulmonary hypertension and right ventricular dysfunction can complicate lung transplant. Pulmonary artery pressures affect outcome are uncertain during wait list. We evaluated changes in wait list pulmonary artery pressures on survival after lung transplant. Materials and Methods: We queried the United Network for Organ Sharing/Standard Transplant Analysis and Research registry from 1987 to 2012 for all lung transplants. Recipients with unique pulmonary artery pressure measurements upon listing and transplant were included. Mean pulmonary artery pressure was rated as increased (increase > 5 mm Hg), decreased (decrease > 5 mm Hg), or unchanged (variation < 5 mm Hg). Results: There were 23 951 lung transplants and 1677 recipients were included. Diagnoses demonstrated significant changes in mean pulmonary artery pressure during the listing period ( P ≤ .0001). In recipients with chronic obstructive pulmonary disease, survival was poorer when mean pulmonary artery pressure was increased than decreased ( P ≤ .03). In recipients with primary pulmonary hypertension, survival was poorer when mean pulmonary artery pressure was decreased than increased ( P ≤ .02). Proportional hazards analysis showed that increases in mean pulmonary artery pressure independently affected survival (hazard ratio, 0.78; 95% confidence interval, 0.62-0.96). Conclusions: Although the mechanism is unknown, an increase in mean pulmonary artery pressure in patients with chronic obstructive pulmonary disease is associated with poorer survival after lung transplant. In contrast, patients with primary pulmonary hypertension with decreased mean pulmonary artery pressure have poorer survival after lung transplant. In patients with primary pulmonary hypertension, changes in pulmonary artery pressure may be a surrogate for a failing right ventricular function. In chronic obstructive pulmonary disease, the change in pressure suggests an undetermined progressive process. Further study of right ventricular function is warranted to determine the effects of changes in pulmonary artery pressure on lung transplant recipients.
机译:目的:肺动脉高压和右心功能不全会使肺移植复杂化。在等待名单期间,肺动脉压力会影响预后。我们评估了肺移植后等待列表中肺动脉压力对存活率的变化。材料和方法:我们查询了1987年至2012年间所有器官移植的器官共享/标准移植物分析和研究联合网络。包括在上市和移植后具有独特肺动脉压测量值的收件人。平均肺动脉压被评定为升高(升高> 5 mm Hg),降低(降低> 5 mm Hg)或未改变(变化<5 mm Hg)。结果:共进行了23 951例肺移植,包括1677例接受者。诊断表明在上市期间平均肺动脉压发生了显着变化(P≤.0001)。在患有慢性阻塞性肺疾病的接受者中,平均肺动脉压升高而不是降低(P≤.03),生存期较差。在原发性肺动脉高压的接受者中,平均肺动脉压降低而不是升高(P≤.02),生存期较差。比例风险分析表明,平均肺动脉压升高独立影响生存率(风险比,0.78; 95%置信区间,0.62-0.96)。结论:尽管机制尚不清楚,但慢性阻塞性肺疾病患者的平均肺动脉压升高与肺移植后生存期较差有关。相反,原发性肺动脉高压患者的平均肺动脉压降低,肺移植后生存期较差。在患有原发性肺动脉高压的患者中,肺动脉压的改变可能是右心室功能衰竭的替代指标。在慢性阻塞性肺疾病中,压力的变化表明未确定的进行性过程。有必要进一步研究右心室功能,以确定肺动脉压变化对肺移植受者的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号